These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2896669)

  • 21. Evaluation of three broth disk methods for testing the susceptibility of anaerobic bacteria to imipenem.
    Shungu DL; Weinberg E; Cerami AT
    J Clin Microbiol; 1985 Jun; 21(6):875-9. PubMed ID: 3859487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the 10-micrograms clindamycin disk for susceptibility testing of anaerobes by the aerobically incubated thioglycolate broth disk method.
    Toohey KL; Kurzynski TA; Schell RF; Birk RJ; Zabransky RJ
    J Clin Microbiol; 1986 Mar; 23(3):619-21. PubMed ID: 3958150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a EUCAST disk diffusion method for the susceptibility testing of rapidly growing anaerobic bacteria using Fastidious Anaerobe Agar (FAA): a development study using Bacteroides species.
    Bavelaar H; Justesen US; Morris TE; Anderson B; Copsey-Mawer S; Stubhaug TT; Kahlmeter G; Matuschek E
    Clin Microbiol Infect; 2021 Nov; 27(11):1695.e1-1695.e6. PubMed ID: 33813129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility testing of anaerobic bacteria.
    Rosenblatt JE
    Rev Infect Dis; 1984; 6 Suppl 1():S242-8. PubMed ID: 6372033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of ceftriaxone combined with tazobactam against anaerobic bacteria.
    Wüst J; Hardegger U
    Eur J Clin Microbiol Infect Dis; 1994 Feb; 13(2):177-81. PubMed ID: 8013494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):550-1. PubMed ID: 2548866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activity of cefotetan against anaerobic bacteria].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multilaboratory evaluation of an agar diffusion disk susceptibility test for rapidly growing anaerobic bacteria.
    Barry AL; Fuchs PC; Gerlach EH; Allen SD; Acar JF; Aldridge KE; Bourgault AM; Grimm H; Hall GS; Heizmann W
    Rev Infect Dis; 1990; 12 Suppl 2():S210-7. PubMed ID: 2406872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.
    Odou MF; Muller C; Calvet L; Dubreuil L
    J Antimicrob Chemother; 2007 Apr; 59(4):646-51. PubMed ID: 17350985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of anaerobic susceptibility results obtained by two methods of inoculum preparation.
    Bourgault AM; Lamothe F
    J Clin Microbiol; 1984 Dec; 20(6):1060-4. PubMed ID: 6520217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of anaerobic microdilution MIC results with the Prompt Inoculation System.
    Mangels JI
    J Clin Microbiol; 1987 Jun; 25(6):1140-2. PubMed ID: 2885341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
    Werner H; Heizmann W; Luft G
    Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaerobic susceptibility testing. Slight differences in inoculum size can make a difference in minimum inhibitory concentrations.
    Aldridge KE; Schiro DD
    Diagn Microbiol Infect Dis; 1994 Mar; 18(3):191-5. PubMed ID: 7924212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1064-7. PubMed ID: 2559846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility testing of anaerobes with Etest.
    Bolmström A
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S367-70. PubMed ID: 8324149
    [No Abstract]   [Full Text] [Related]  

  • 36. Major methodology-dependent discordant susceptibility results for Bacteroides fragilis group isolates but not other anaerobes.
    Aldridge KE; Schiro DD
    Diagn Microbiol Infect Dis; 1994 Nov; 20(3):135-42. PubMed ID: 7874880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of anaerobic bacteria to PD 131628.
    Nord CE; Hagelbäck A
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):68-71. PubMed ID: 1314176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of susceptibilities of anaerobic bacteria determined by agar dilution and by a microbroth method.
    Baron EJ; Bruckner DA
    Rev Infect Dis; 1984; 6 Suppl 1():S249-53. PubMed ID: 6718938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified agar dilution method for rapid antibiotic susceptibility testing of anaerobic bacteria.
    Hanson CW; Martin WJ
    Antimicrob Agents Chemother; 1978 Mar; 13(3):383-8. PubMed ID: 400819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A; Roudon T
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.